Maynard Um
-
-
-
-
-
-
-
These are the best biotech stocks to own in 2026: BofA
-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on Ocular Therapeutix (OCUL) following study results
-
-
-
-
-
-
-
Increasing unusual put option volume: SCCO OCUL SLS CSGP BAX EQNR VNET MXEF CMBT SYF
-
-
-
-
-
-
-
Ocular Therapeutix (OCUL) PT Raised to $21 at H.C. Wainwright
-
-
-
-
-
-
-
Ocular Therapeutix (OCUL) PT Raised to $19 at H.C. Wainwright
-
-
-
-
-
-
-
TD Cowen on Ocular Therapeutix (OCUL): 'SOL-1 Data In Q1:2026 Should Be Positive And Clinically Relevant'
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Ocular Therapeutix (OCUL)
-
405,730 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

